{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:46:25Z","timestamp":1789775185746,"version":"4.0.1"},"reference-count":297,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403197"],"award-info":[{"award-number":["82403197"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["ZYGD23017"],"award-info":[{"award-number":["ZYGD23017"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["2024HXBH106"],"award-info":[{"award-number":["2024HXBH106"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M752248"],"award-info":[{"award-number":["2024M752248"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["BX20230244"],"award-info":[{"award-number":["BX20230244"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bbcan.2025.189356","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T11:51:46Z","timestamp":1748433106000},"page":"189356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Epigenetic mechanisms in non-small cell lung cancer therapy and chemoresistance"],"prefix":"10.1016","volume":"1880","author":[{"given":"Ying","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2025.189356_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbcan.2025.189356_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12916-024-03844-8","article-title":"Non-small cell lung cancer in ever-smokers vs never-smokers","volume":"23","author":"Burt","year":"2025","journal-title":"BMC Med."},{"key":"10.1016\/j.bbcan.2025.189356_bb0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41571-023-00844-0","article-title":"Lung cancer in patients who have never smoked - an emerging disease","volume":"21","author":"LoPiccolo","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","article-title":"Non-small-cell lung cancer","volume":"10","author":"Hendriks","year":"2024","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.bbcan.2025.189356_bb0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00408-025-00801-x","article-title":"Update 2025: management of non-small-cell lung cancer","volume":"203","author":"Jeon","year":"2025","journal-title":"Lung"},{"key":"10.1016\/j.bbcan.2025.189356_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108347","article-title":"Therapeutic strategies for non-small cell lung cancer: experimental models and emerging biomarkers to monitor drug efficacies","volume":"242","author":"Bourreau","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbcan.2025.189356_bb0035","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s12272-021-01312-y","article-title":"Mechanisms of resistance to chemotherapy in non-small cell lung cancer","volume":"44","author":"Min","year":"2021","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bbcan.2025.189356_bb0040","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(24)01029-8","article-title":"New promises and challenges in the treatment of advanced non-small-cell lung cancer","volume":"404","author":"Meyer","year":"2024","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.bbcan.2025.189356_bb0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41571-024-00971-2","article-title":"The changing treatment landscape of EGFR-mutant non-small-cell lung cancer","volume":"22","author":"Zhou","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0050","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1002\/cncr.35423","article-title":"Top advances of the year: targeted therapy for lung cancer","volume":"130","author":"Makarem","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb0055","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.semcancer.2017.09.005","article-title":"Lung cancer epigenetics: from knowledge to applications","volume":"51","author":"Duruisseaux","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2025.189356_bb0065","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3892\/ijo.2024.5714","article-title":"Non-coding RNA-mediated epigenetic modification of ferroptosis in non-small cell lung cancer (review)","volume":"66","author":"Wang","year":"2025","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev-med-111314-035900","article-title":"Epigenetic therapeutics: a new weapon in the war against cancer","volume":"67","author":"Ahuja","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbcan.2025.189356_bb0075","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038000","article-title":"Targeting epigenetics in lung cancer","volume":"11","author":"Chao","year":"2021","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.bbcan.2025.189356_bb0080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/ije\/dyr184","article-title":"The epigenotype. 1942","volume":"41","author":"Waddington","year":"2012","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0085","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41586-019-1411-0","article-title":"Advances in epigenetics link genetics to the environment and disease","volume":"571","author":"Cavalli","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2025.189356_bb0090","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41392-023-01720-0","article-title":"Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2025.189356_bb0095","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12943-023-01810-1","article-title":"Epigenetic modification of m6A regulator proteins in cancer","volume":"22","author":"Wang","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb0100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41392-023-01341-7","article-title":"Targeting epigenetic regulators to overcome drug resistance in cancers","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2025.189356_bb0105","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41576-020-0270-8","article-title":"The evolving metabolic landscape of chromatin biology and epigenetics","volume":"21","author":"Dai","year":"2020","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbcan.2025.189356_bb0110","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.tibs.2020.05.009","article-title":"Nothing is yet set in (hi)stone: novel post-translational modifications regulating chromatin function","volume":"45","author":"Chan","year":"2020","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb0115","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.molcel.2025.02.011","article-title":"The role of protein lactylation: a kaleidoscopic post-translational modification in cancer","volume":"85","author":"Iozzo","year":"2025","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2025.189356_bb0120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12272-019-01126-z","article-title":"Targeting epigenetics for cancer therapy","volume":"42","author":"Park","year":"2019","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bbcan.2025.189356_bb0125","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","article-title":"Targeting the epigenetic regulation of antitumour immunity","volume":"19","author":"Hogg","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbcan.2025.189356_bb0130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41392-019-0095-0","article-title":"Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials","volume":"4","author":"Cheng","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2025.189356_bb0135","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.semcancer.2021.03.025","article-title":"Cancer epigenetics: past, present and future","volume":"83","author":"Lee","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0140","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/301089a0","article-title":"Hypomethylation distinguishes genes of some human cancers from their normal counterparts","volume":"301","author":"Feinberg","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2025.189356_bb0145","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41576-021-00348-6","article-title":"Origins of human disease: the chrono-epigenetic perspective","volume":"22","author":"Oh","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbcan.2025.189356_bb0150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.semcancer.2021.01.005","article-title":"Targeting DNA methyltransferases in non-small-cell lung cancer","volume":"83","author":"Al-Yozbaki","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0155","article-title":"Epigenetic alterations and inflammation as emerging use for the advancement of treatment in non-small cell lung cancer","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0160","doi-asserted-by":"crossref","first-page":"11701","DOI":"10.3390\/ijms222111701","article-title":"Histone modification in NSCLC: molecular mechanisms and therapeutic targets","volume":"22","author":"Bajbouj","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101673","article-title":"Unraveling the post-translational modifications and therapeutical approach in NSCLC pathogenesis","volume":"33","author":"Gulhane","year":"2023","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112202","article-title":"DNA methylation in lung cancer patients: opening a \u201cwindow of life\u201d under precision medicine","volume":"144","author":"Liang","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbcan.2025.189356_bb0175","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/321209a0","article-title":"CpG-rich islands and the function of DNA methylation","volume":"321","author":"Bird","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2025.189356_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100938","article-title":"Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms","volume":"68","author":"Li","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bbcan.2025.189356_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1337","article-title":"RNautophagic regulation of DNMT3a-dependent DNA methylation by Linc00942 enhances chemoresistance in gastric cancer","volume":"13","author":"Zhu","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbcan.2025.189356_bb0190","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1158\/0008-5472.CAN-09-3427","article-title":"Identification of hypermethylated genes associated with cisplatin resistance in human cancers","volume":"70","author":"Chang","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189356_bb0195","doi-asserted-by":"crossref","first-page":"896","DOI":"10.4161\/epi.28601","article-title":"Integrated analysis of DNA methylation and mRNA expression profiling reveals candidate genes associated with cisplatin resistance in non-small cell lung cancer","volume":"9","author":"Zhang","year":"2014","journal-title":"Epigenetics"},{"key":"10.1016\/j.bbcan.2025.189356_bb0200","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13073-018-0562-1","article-title":"Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance","volume":"10","author":"Grasse","year":"2018","journal-title":"Genome Med."},{"key":"10.1016\/j.bbcan.2025.189356_bb0205","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.biocel.2013.07.013","article-title":"Epigenetic downregulation of RUNX3 by DNA methylation induces docetaxel chemoresistance in human lung adenocarcinoma cells by activation of the AKT pathway","volume":"45","author":"Zheng","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0210","first-page":"100","article-title":"DNA methylation of DKK3 modulates docetaxel chemoresistance in human nonsmall cell lung cancer cell","volume":"30","author":"Tao","year":"2015","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.bbcan.2025.189356_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2022","article-title":"DNA methyltransferases in virus-associated cancers","volume":"29","author":"Charostad","year":"2019","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0220","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2174\/138920209788920994","article-title":"Potential of DNMT and its epigenetic regulation for lung cancer therapy","volume":"10","author":"Tang","year":"2009","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.bbcan.2025.189356_bb0225","doi-asserted-by":"crossref","first-page":"8905","DOI":"10.1073\/pnas.0501034102","article-title":"Recruitment of DNA methyltransferase I to DNA repair sites","volume":"102","author":"Mortusewicz","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb0230","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/abbs\/gmw050","article-title":"Biological function and regulation of histone and non-histone lysine methylation in response to DNA damage","volume":"48","author":"Chen","year":"2016","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.bbcan.2025.189356_bb0235","doi-asserted-by":"crossref","first-page":"9005","DOI":"10.1158\/0008-5472.CAN-08-1276","article-title":"Carcinogen-induced gene promoter hypermethylation is mediated by DNMT1 and causal for transformation of immortalized bronchial epithelial cells","volume":"68","author":"Damiani","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189356_bb0240","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1172\/JCI40706","article-title":"The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients","volume":"120","author":"Lin","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2025.189356_bb0245","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ccr.2011.09.012","article-title":"Oxidative damage targets complexes containing DNA methyltransferases, SIRT1 and Polycomb members to promoter CpG Islands","volume":"20","author":"O\u2019Hagan","year":"2011","journal-title":"Cancer Cell"},{"issue":"63","key":"10.1016\/j.bbcan.2025.189356_bb0250","first-page":"7089","volume":"1","author":"Belinsky","year":"2003","journal-title":"Inhibition of DNA Methylation and Histone Deacetylation Prevents Murine Lung Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb0255","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/cncr.22087","article-title":"Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer","volume":"107","author":"Kim","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb0260","article-title":"Targeting MGST1 makes non-small cell lung cancer cells sensitive to radiotherapy by epigenetically enhancing ALOX15-mediated ferroptosis","author":"Ma","year":"2024","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bbcan.2025.189356_bb0265","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1073\/pnas.93.9.4045","article-title":"Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer","volume":"93","author":"Belinsky","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb0270","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1158\/0008-5472.CAN-03-3046","article-title":"RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells","volume":"64","author":"Suzuki","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189356_bb0275","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.lungcan.2006.10.022","article-title":"Alteration of DNA methyltransferases contributes to 5\u2032CpG methylation and poor prognosis in lung cancer","volume":"55","author":"Lin","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb0280","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nm0795-686","article-title":"5\u2032 CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16\/CDKN2\/MTS1 in human cancers","volume":"1","author":"Merlo","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2025.189356_bb0285","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/375503a0","article-title":"Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16","volume":"375","author":"Lukas","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2025.189356_bb0290","doi-asserted-by":"crossref","first-page":"11891","DOI":"10.1073\/pnas.95.20.11891","article-title":"Aberrant methylation of p16 INK4a is an early event in lung cancer and a potential biomarker for early diagnosis","volume":"95","author":"Belinsky","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb0295","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4149\/neo_2024_240925N403","article-title":"Methylation status of selected genes in non-small cell lung carcinoma - current knowledge and future perspectives","volume":"71","author":"Put","year":"2024","journal-title":"Neoplasma"},{"key":"10.1016\/j.bbcan.2025.189356_bb0300","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4046\/trd.2012.73.1.11","article-title":"Promoter methylation of CDKN2A, RAR\u03b2, and RASSF1A in non-small cell lung carcinoma: quantitative evaluation using pyrosequencing","volume":"73","author":"Lee","year":"2012","journal-title":"Tuberc. Respir. Dis."},{"key":"10.1016\/j.bbcan.2025.189356_bb0305","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1101\/gad.276568.115","article-title":"Role of TET enzymes in DNA methylation, development, and cancer","volume":"30","author":"Rasmussen","year":"2016","journal-title":"Genes Dev."},{"issue":"268","key":"10.1016\/j.bbcan.2025.189356_bb0310","article-title":"Epigenetic silencing of TET1 mediated hydroxymethylation of base excision repair pathway during lung carcinogenesis","volume":"1987","author":"Chen","year":"2021","journal-title":"Environ. Pollut. Barking Essex"},{"key":"10.1016\/j.bbcan.2025.189356_bb0315","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.celrep.2016.05.087","article-title":"Oncogenic EGFR represses the TET1 DNA demethylase to induce silencing of tumor suppressors in cancer cells","volume":"16","author":"Forloni","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2025.189356_bb0320","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.7150\/jca.26482","article-title":"P16 methylation leads to paclitaxel resistance of advanced non-small cell lung cancer","volume":"10","author":"Liu","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb0325","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/carcin\/bgh045","article-title":"Methylated DNA-binding protein 2 antisense inhibitors suppress tumourigenesis of human cancer cell lines in vitro and in vivo","volume":"25","author":"Campbell","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2025.189356_bb0330","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13148-021-01069-7","article-title":"Advances in epigenetic therapeutics with focus on solid tumors","volume":"13","author":"Jin","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.bbcan.2025.189356_bb0335","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41576-022-00468-7","article-title":"Histone post-translational modifications - cause and consequence of genome function","volume":"23","author":"Mill\u00e1n-Zambrano","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbcan.2025.189356_bb0340","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/s12276-023-01014-z","article-title":"Histone modifications in drug-resistant cancers: from a cancer stem cell and immune evasion perspective","volume":"55","author":"Jin","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbcan.2025.189356_bb0345","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/jcp.22589","article-title":"Knockdown of CITED2 using short-hairpin RNA sensitizes cancer cells to cisplatin through stabilization of p53 and enhancement of p53-dependent apoptosis","volume":"226","author":"Wu","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0350","doi-asserted-by":"crossref","first-page":"18218","DOI":"10.1074\/jbc.M802332200","article-title":"Tip60 is regulated by circadian transcription factor clock and is involved in cisplatin resistance","volume":"283","author":"Miyamoto","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2025.189356_bb0355","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/emboj.2010.333","article-title":"Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin","volume":"30","author":"Edmond","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2025.189356_bb0360","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/carcin\/bgr292","article-title":"Activation of a Tip60\/E2F1\/ERCC1 network in human lung adenocarcinoma cells exposed to cisplatin","volume":"33","author":"Van Den Broeck","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2025.189356_bb0365","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.bbagrm.2016.06.002","article-title":"MDR1 mediated chemoresistance: BMI1 and TIP60 in action","volume":"1859","author":"Banerjee Mustafi","year":"2016","journal-title":"Biochim. Biophys. Acta BBA - Gene Regul. Mech."},{"key":"10.1016\/j.bbcan.2025.189356_bb0370","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.3390\/cells11193094","article-title":"Combination of paclitaxel and PXR antagonist SPA70 reverses paclitaxel-resistant non-small cell lung cancer","volume":"11","author":"Niu","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2025.189356_bb0375","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1158\/1541-7786.MCR-09-0458","article-title":"Enhanced expression of PCAF endows apoptosis resistance in cisplatin-resistant cells","volume":"8","author":"Hirano","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189356_bb0380","doi-asserted-by":"crossref","first-page":"e2746","DOI":"10.1038\/cddis.2016.409","article-title":"Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1\/HDAC activity","volume":"8","author":"Wang","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189356_bb0385","doi-asserted-by":"crossref","first-page":"e2063","DOI":"10.1038\/cddis.2015.328","article-title":"Targeting HDAC with a novel inhibitor effectively reverses paclitaxel resistance in non-small cell lung cancer via multiple mechanisms","volume":"7","author":"Wang","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189356_bb0390","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41419-023-05869-y","article-title":"Nuclear complement C3b promotes paclitaxel resistance by assembling the SIN3A\/HDAC1\/2 complex in non-small cell lung cancer","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189356_bb0395","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1515\/hsz-2016-0307","article-title":"Valproic acid (VPA) enhances cisplatin sensitivity of non-small cell lung cancer cells via HDAC2 mediated down regulation of ABCA1","volume":"398","author":"Chen","year":"2017","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbcan.2025.189356_bb0400","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12967-023-03973-3","article-title":"HDAC inhibitor ITF2357 reduces resistance of mutant-KRAS non-small cell lung cancer to pemetrexed through a HDAC2\/miR-130a-3p-dependent mechanism","volume":"21","author":"Cui","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2025.189356_bb0405","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.7150\/thno.29673","article-title":"Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1\u03b1-mediated regulation of apoptosis and autophagy","volume":"9","author":"Zhang","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2025.189356_bb0410","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41419-020-2519-8","article-title":"The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53","volume":"11","author":"Hu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189356_bb0415","article-title":"Implications of the USP10-HDAC6 axis in lung cancer - a path to precision medicine","volume":"2","author":"Zhang","year":"2021","journal-title":"J. Cancer Biol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0420","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1038\/s41598-020-61295-6","article-title":"Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2","volume":"10","author":"Bora-Singhal","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2025.189356_bb0425","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41419-019-1592-3","article-title":"SIRT1 deacetylated and stabilized XRCC1 to promote chemoresistance in lung cancer","volume":"10","author":"Yousafzai","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189356_bb0430","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1158\/0008-5472.CAN-13-2620","article-title":"SIRT1 and AMPK mediate hypoxia-induced resistance of non\u2013small cell lung cancers to cisplatin and doxorubicin","volume":"74","author":"Shin","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189356_bb0435","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/s12276-023-01091-0","article-title":"Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer","volume":"55","author":"Shin","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbcan.2025.189356_bb0440","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1080\/21655979.2021.1993718","article-title":"MicroRNA-326 impairs chemotherapy resistance in non small cell lung cancer by suppressing histone deacetylase SIRT1-mediated HIF1\u03b1 and elevating VEGFA","volume":"13","author":"Wei","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.bbcan.2025.189356_bb0445","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1039\/C8RA09914F","article-title":"miR-124 and miR-142 enhance cisplatin sensitivity of non-small cell lung cancer cells through repressing autophagy via directly targeting SIRT1","volume":"9","author":"Song","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.bbcan.2025.189356_bb0450","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/cam4.3728","article-title":"SIRT3 promotion reduces resistance to cisplatin in lung cancer by modulating the FOXO3\/CDT1 axis","volume":"10","author":"Cao","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbcan.2025.189356_bb0455","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jso.23975","article-title":"SIRT6 expression is associated with poor prognosis and chemosensitivity in patients with non-small cell lung cancer","volume":"112","author":"Azuma","year":"2015","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175853","article-title":"Isoorientin reverses lung cancer drug resistance by promoting ferroptosis via the SIRT6\/Nrf2\/GPX4 signaling pathway","volume":"954","author":"Feng","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0465","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bbrc.2018.10.089","article-title":"Depletion of SIRT7 sensitizes human non-small cell lung cancer cells to gemcitabine therapy by inhibiting autophagy","volume":"506","author":"Jiang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2025.189356_bb0470","first-page":"147","article-title":"The expression and significance of the enhancer of zeste homolog 2 in lung adenocarcinoma","volume":"28","author":"Lv","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2025.189356_bb0475","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.lungcan.2014.09.010","article-title":"Expression of the enhancer of zeste homolog 2 in biopsy specimen predicts chemoresistance and survival in advanced non-small cell lung cancer receiving first-line platinum-based chemotherapy","volume":"86","author":"Xu","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb0480","first-page":"26","article-title":"Downregulation of histone-lysine N-methyltransferase EZH2 inhibits cell viability and enhances chemosensitivity in lung cancer cells","volume":"21","author":"Cao","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2025.189356_bb0485","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.7150\/thno.29463","article-title":"HOXB13 networking with ABCG1\/EZH2\/Slug mediates metastasis and confers resistance to cisplatin in lung adenocarcinoma patients","volume":"9","author":"Zhan","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2025.189356_bb0490","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.omtn.2021.01.013","article-title":"Long non-coding RNA linc00665 inhibits CDKN1C expression by binding to EZH2 and affects cisplatin sensitivity of NSCLC cells","volume":"23","author":"Yang","year":"2021","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"10.1016\/j.bbcan.2025.189356_bb0495","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature14122","article-title":"EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumors to TopoII inhibitors","volume":"520","author":"Fillmore","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2025.189356_bb0500","article-title":"EZH2\/G9a interact to mediate drug resistance in non-small-cell lung cancer by regulating the SMAD4\/ERK\/c-Myc signaling axis","volume":"43","author":"Zhang","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2025.189356_bb0505","first-page":"318","article-title":"An SETD1A\/Wnt\/\u03b2-catenin feedback loop promotes NSCLC development","volume":"40","author":"Wang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.bbcan.2025.189356_bb0510","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41388-018-0429-3","article-title":"Acquired SETD2 mutation and impaired CREB1 activation confer cisplatin resistance in metastatic non-small cell lung cancer","volume":"38","author":"Kim","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2025.189356_bb0515","article-title":"Gain-of-function mutations in the catalytic domain of DOT1L promote lung cancer malignant phenotypes via the MAPK\/ERK signaling pathway","volume":"9","author":"Zhang","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbcan.2025.189356_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2020.102953","article-title":"PRMT1 is critical to FEN1 expression and drug resistance in lung cancer cells","volume":"95","author":"He","year":"2020","journal-title":"DNA Repair"},{"key":"10.1016\/j.bbcan.2025.189356_bb0525","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2024055118","article-title":"Acquired resistance to PRMT5 inhibition induces concomitant collateral sensitivity to paclitaxel","volume":"118","author":"Mueller","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb0530","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/cbin.12066","article-title":"The PRMT5 inhibitor C9 mitigates hypoxia-induced carboplatin resistance in lung cancer by inducing autophagy","volume":"47","author":"Fan","year":"2023","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.bbcan.2025.189356_bb0535","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1002\/cbin.11449","article-title":"Circular RNA PRMT5 confers cisplatin-resistance via miR-4458\/REV3L axis in non-small-cell lung cancer","volume":"44","author":"Pang","year":"2020","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.bbcan.2025.189356_bb0540","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.3390\/ijms22116131","article-title":"PRMT5 selective inhibitor enhances therapeutic efficacy of cisplatin in lung cancer cells","volume":"22","author":"Bajbouj","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb0545","first-page":"64","article-title":"The arginine methyltransferase PRMT5 and PRMT1 distinctly regulate the degradation of anti-apoptotic protein CFLARL in human lung cancer cells","volume":"38","author":"Li","year":"2019","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.bbcan.2025.189356_bb0550","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.apsb.2022.05.019","article-title":"PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD\/ENO1 mediated cell metabolism","volume":"13","author":"Sun","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bbcan.2025.189356_bb0555","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.celrep.2017.04.077","article-title":"Taxane-platin-resistant lung cancers co-develop hypersensitivity to JumonjiC demethylase inhibitors","volume":"19","author":"Dalvi","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2025.189356_bb0560","first-page":"593","article-title":"Histone demethylase KDM5A enhances cell proliferation, induces EMT in lung adenocarcinoma cells, and have a strong causal association with paclitaxel resistance","volume":"68","author":"Xu","year":"2021","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0565","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13148-018-0533-9","article-title":"Histone demethylase JARID1B\/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor","volume":"10","author":"Kuo","year":"2018","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.bbcan.2025.189356_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101778","article-title":"Histone demethylase KDM6A coordinating with KMT2B regulates self-renewal and chemoresistance of non-small cell lung cancer stem cells","volume":"37","author":"Chen","year":"2023","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0575","first-page":"2828","article-title":"Circ-CUL2\/microRNA-888-5p\/RB1CC1 axis participates in cisplatin resistance in NSCLC via repressing cell advancement","volume":"13","author":"Chen","year":"2025","journal-title":"Bioengineered"},{"key":"10.1016\/j.bbcan.2025.189356_bb0580","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1158\/1078-0432.CCR-19-1237","article-title":"Role of KEAP1\/NFE2L2 mutations in the chemotherapeutic response of patients with non\u2013small cell lung cancer","volume":"26","author":"Jeong","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189356_bb0585","doi-asserted-by":"crossref","first-page":"1242137","DOI":"10.3389\/fgene.2023.1242137","article-title":"Histone ubiquitination-related gene CUL4B promotes lung adenocarcinoma progression and cisplatin resistance","volume":"14","author":"Yin","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.bbcan.2025.189356_bb0590","doi-asserted-by":"crossref","DOI":"10.21037\/jtd-23-1110","article-title":"Cullin7 induces docetaxel resistance by regulating the protein level of the antiapoptotic protein Survivin in lung adenocarcinoma cells","volume":"15","author":"Li","year":"2023","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.bbcan.2025.189356_bb0595","article-title":"E3 ubiquitin ligase Hakai regulates cell growth and invasion, and increases the chemosensitivity to cisplatin in non\u2011small\u2011cell lung cancer cells","author":"Liu","year":"2018","journal-title":"Int. J. Mol. Med. 42,1145-1151."},{"key":"10.1016\/j.bbcan.2025.189356_bb0600","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/CAD.0000000000001562","article-title":"USP3 promotes cisplatin resistance in non-small cell lung cancer cells by suppressing ACOT7-regulated ferroptosis","volume":"35","author":"Tao","year":"2024","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.bbcan.2025.189356_bb0605","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3892\/ol.2020.11568","article-title":"Ubiquitin-specific peptidase 17 promotes cisplatin resistance via PI3K\/AKT activation in non-small cell lung cancer","volume":"20","author":"Zhang","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2025.189356_bb0610","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fphar.2017.00274","article-title":"USP22 induces cisplatin resistance in lung adenocarcinoma by regulating \u03b3H2AX-mediated DNA damage repair and Ku70\/Bax-mediated apoptosis","volume":"8","author":"Wang","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0615","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1158\/1541-7786.MCR-18-0042","article-title":"Targeting USP22 suppresses tumorigenicity and enhances cisplatin sensitivity through ALDH1A3 downregulation in cancer-initiating cells from lung adenocarcinoma","volume":"16","author":"Yun","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189356_bb0620","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41419-020-03008-5","article-title":"USP29 enhances chemotherapy-induced stemness in non-small cell lung cancer via stabilizing Snail1 in response to oxidative stress","volume":"11","author":"Wu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189356_bb0625","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41374-021-00725-z","article-title":"Ubiquitin-specific protease 35 (USP35) mediates cisplatin-induced apoptosis by stabilizing BIRC3 in non-small cell lung cancer","volume":"102","author":"Liu","year":"2022","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0630","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/bab.2386","article-title":"The role of USP51 in attenuating chemosensitivity of lung cancer cells to cisplatin by regulating DNA damage response","volume":"70","author":"Zhou","year":"2023","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.bbcan.2025.189356_bb0635","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3892\/mmr.2020.11188","article-title":"Knockdown of ubiquitin-specific protease 51 attenuates cisplatin resistance in lung cancer through ubiquitination of zinc-finger E-box binding homeobox 1","volume":"22","author":"Zhou","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbcan.2025.189356_bb0640","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/cac2.12460","article-title":"USP51\/PD-L1\/ITGB1-deployed juxtacrine interaction plays a cell-intrinsic role in promoting chemoresistant phenotypes in non-small cell lung cancer","volume":"43","author":"Li","year":"2023","journal-title":"Cancer Commun."},{"key":"10.1016\/j.bbcan.2025.189356_bb0645","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.tplants.2015.07.005","article-title":"Histone acetylation enzymes coordinate metabolism and gene expression","volume":"20","author":"Shen","year":"2015","journal-title":"Trends Plant Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb0650","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature05915","article-title":"The complex language of chromatin regulation during transcription","volume":"447","author":"Berger","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2025.189356_bb0655","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41580-021-00441-y","article-title":"Modulation of cellular processes by histone and non-histone protein acetylation","volume":"23","author":"Shvedunova","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0660","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/emboj\/cdg219","article-title":"A role for cofactor-cofactor and cofactor-histone interactions in targeting p300, SWI\/SNF and mediator for transcription","volume":"22","author":"Huang","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2025.189356_bb0665","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/onc.2010.592","article-title":"Histone acetylation by CBP and p300 at double-strand break sites facilitates SWI\/SNF chromatin remodeling and the recruitment of non-homologous end joining factors","volume":"30","author":"Ogiwara","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2025.189356_bb0670","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1158\/1078-0432.512.11.2","article-title":"Mutations and deletions of the CBP gene in human lung cancer","volume":"11","author":"Kishimoto","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189356_bb0675","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.2217\/epi.15.76","article-title":"A bivalent role of TIP60 histone acetyl transferase in human cancer","volume":"7","author":"Judes","year":"2015","journal-title":"Epigenomics"},{"key":"10.1016\/j.bbcan.2025.189356_bb0680","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1111\/cas.15785","article-title":"TIP60 is required for tumorigenesis in non-small cell lung cancer","volume":"114","author":"Shibahara","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb0685","doi-asserted-by":"crossref","first-page":"30830","DOI":"10.1074\/jbc.M402403200","article-title":"Specific role for p300\/CREB-binding protein-associated factor activity in E2F1 stabilization in response to DNA damage","volume":"279","author":"Ianari","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2025.189356_bb0690","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/ncb998","article-title":"Differential regulation of E2F1 apoptotic target genes in response to DNA damage","volume":"5","author":"Pediconi","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0695","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41586-020-1933-5","article-title":"Structure of the transcription coactivator SAGA","volume":"577","author":"Wang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2025.189356_bb0700","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.tibs.2020.03.001","article-title":"SAGA structures provide mechanistic models for gene activation","volume":"45","author":"Soffers","year":"2020","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb0705","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.neo.2019.03.011","article-title":"Epigenetically down-regulated acetyltransferase PCAF increases the resistance of colorectal cancer to 5-fluorouracil","volume":"21","author":"Liu","year":"2019","journal-title":"Neoplasia N. Y. N"},{"key":"10.1016\/j.bbcan.2025.189356_bb0710","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41419-022-05406-3","article-title":"Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC\/PCAF\/AKT axis","volume":"14","author":"Guo","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189356_bb0715","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.molonc.2012.07.003","article-title":"Histone deacetylases and cancer","volume":"6","author":"Barneda-Zahonero","year":"2012","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0720","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrm2346","article-title":"The Rpd3\/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men","volume":"9","author":"Yang","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0725","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00412-013-0441-x","article-title":"Transcription and beyond: the role of mammalian class I lysine deacetylases","volume":"123","author":"Moser","year":"2014","journal-title":"Chromosoma"},{"key":"10.1016\/j.bbcan.2025.189356_bb0730","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1002\/jcb.24090","article-title":"HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins","volume":"113","author":"Jung","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbcan.2025.189356_bb0735","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/mc.23132","article-title":"Novel genetic variants in HDAC2 and PPARGC1A genes of the CREB-binding protein pathway predict survival of non-small cell lung cancer","volume":"59","author":"Tang","year":"2020","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bbcan.2025.189356_bb0740","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/ijc.27907","article-title":"RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma","volume":"132","author":"Tennstedt","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb0745","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ijc.20395","article-title":"Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients","volume":"112","author":"Osada","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb0750","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.3390\/ijms20246140","article-title":"Hypoxia: overview on hypoxia-mediated mechanisms with a focus on the role of HIF genes","volume":"20","author":"Tirpe","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb0755","article-title":"Notch signaling and non-small cell lung cancer (review)","author":"Zou","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2025.189356_bb0760","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.tranon.2019.11.001","article-title":"Inhibition of HDAC6 attenuates tumor growth of non-small cell lung cancer","volume":"13","author":"Deskin","year":"2019","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0765","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrm3293","article-title":"Sirtuins as regulators of metabolism and healthspan","volume":"13","author":"Houtkooper","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0770","article-title":"SIRT1 expression is associated with the chemotherapy response and prognosis of patients with advanced NSCLC","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2025.189356_bb0775","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1242\/jcs.128272","article-title":"Damage response of XRCC1 at sites of DNA single strand breaks is regulated by phosphorylation and ubiquitylation after degradation of poly(ADP-ribose)","volume":"126","author":"Wei","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb0780","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/mc.23799","article-title":"SIRT1 silencing promotes EMT and Crizotinib resistance by regulating autophagy through AMPK\/mTOR\/S6K signaling pathway in EML4-ALK L1196M and EML4-ALK G1202R mutant non-small cell lung cancer cells","volume":"63","author":"Yang","year":"2024","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bbcan.2025.189356_bb0785","doi-asserted-by":"crossref","first-page":"10899","DOI":"10.1158\/0008-5472.CAN-07-2837","article-title":"Deregulated overexpression of hCdt1 and hCdc6 promotes malignant behavior","volume":"67","author":"Liontos","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189356_bb0790","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1073\/pnas.1203210109","article-title":"Regulation of cell cycle progression by forkhead transcription factor FOXO3 through its binding partner DNA replication factor Cdt1","volume":"109","author":"Zhang","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb0795","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1124\/pr.111.005637","article-title":"Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes","volume":"64","author":"Shen","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbcan.2025.189356_bb0800","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejmech.2019.01.069","article-title":"Histone methyl transferases: a class of epigenetic opportunities to counter uncontrolled cell proliferation","volume":"166","author":"Singh","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbcan.2025.189356_bb0805","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","author":"The Cancer Genome Atlas Research Network","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2025.189356_bb0810","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13148-018-0583-z","article-title":"Tackling malignant melanoma epigenetically: histone lysine methylation","volume":"10","author":"Orouji","year":"2018","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.bbcan.2025.189356_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108790","article-title":"Role of protein arginine methyltransferase 5 in human cancers","volume":"114","author":"Xiao","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbcan.2025.189356_bb0820","doi-asserted-by":"crossref","first-page":"652","DOI":"10.7150\/ijbs.19108","article-title":"Ezh2 acts as a tumor suppressor in Kras-driven lung adenocarcinoma","volume":"13","author":"Wang","year":"2017","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb0825","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1475-2867-8-15","article-title":"Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells","volume":"8","author":"Watanabe","year":"2008","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2025.189356_bb0830","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1593\/neo.04160","article-title":"Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis","volume":"6","author":"Breuer","year":"2004","journal-title":"Neoplasia,"},{"key":"10.1016\/j.bbcan.2025.189356_bb0835","doi-asserted-by":"crossref","first-page":"6556","DOI":"10.1158\/1078-0432.CCR-12-3946","article-title":"EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non\u2013small cell lung carcinoma","volume":"19","author":"Behrens","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189356_bb0840","series-title":"HOXB13 Suppresses de Novo Lipogenesis through HDAC3-Mediated Epigenetic Reprogramming","author":"Lu","year":"2021"},{"key":"10.1016\/j.bbcan.2025.189356_bb0845","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cell.2007.05.009","article-title":"High-resolution profiling of histone methylations in the human genome","volume":"129","author":"Barski","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2025.189356_bb0850","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbrc.2021.05.026","article-title":"The H3K4 methyltransferase SETD1A is required for proliferation of non-small cell lung cancer cells by promoting S-phase progression","volume":"561","author":"Kang","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2025.189356_bb0855","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.2174\/0929867330666230525143252","article-title":"SETD1A-mediated methylation of H3K4me3 inhibits ferroptosis in non-small cell lung cancer by regulating the WTAPP1\/WTAP Axis","volume":"31","author":"Wang","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbcan.2025.189356_bb0860","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1111\/1759-7714.15037","article-title":"SETD1A-mediated H3K4me3 methylation upregulates lncRNA HOXC-AS3 and the binding of HOXC-AS3 to EP300 and increases EP300 stability to suppress the ferroptosis of NSCLC cells","volume":"14","author":"Shi","year":"2023","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb0865","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrm3274","article-title":"Understanding the language of Lys36 methylation at histone H3","volume":"13","author":"Wagner","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0870","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.canlet.2014.11.024","article-title":"Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer","volume":"357","author":"Hao","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2025.189356_bb0875","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jpha.2022.11.009","article-title":"Novel insights into histone lysine methyltransferases in cancer therapy: from epigenetic regulation to selective drugs","volume":"13","author":"Liao","year":"2023","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.bbcan.2025.189356_bb0880","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.tibs.2011.09.001","article-title":"Versatility of PRMT5-induced methylation in growth control and development","volume":"36","author":"Karkhanis","year":"2011","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb0885","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s12276-021-00613-y","article-title":"Protein arginine methyltransferases: promising targets for cancer therapy","volume":"53","author":"Hwang","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbcan.2025.189356_bb0890","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12964-024-01506-z","article-title":"PRMT1 in human neoplasm: cancer biology and potential therapeutic target","volume":"22","author":"Shen","year":"2024","journal-title":"Cell Commun. Signal. CCS"},{"key":"10.1016\/j.bbcan.2025.189356_bb0895","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13046-020-01682-z","article-title":"Histone methyltransferase and drug resistance in cancers","volume":"39","author":"Yang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189356_bb0900","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-biochem-072511-122603","article-title":"Flap endonuclease 1","volume":"82","author":"Balakrishnan","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbcan.2025.189356_bb0905","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nchembio.2148","article-title":"Cellular active N-hydroxyurea FEN1 inhibitors block substrate entry to the active site","volume":"12","author":"Exell","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0910","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/1878-0261.12058","article-title":"FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer","volume":"11","author":"He","year":"2017","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0915","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ajpath.2017.09.011","article-title":"Overexpression of flap endonuclease 1 correlates with enhanced proliferation and poor prognosis of non\u2013small-cell lung cancer","volume":"188","author":"Zhang","year":"2018","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0920","doi-asserted-by":"crossref","first-page":"9630","DOI":"10.1128\/MCB.24.21.9630-9645.2004","article-title":"Human SWI\/SNF-associated PRMT5 Methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes","volume":"24","author":"Pal","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0925","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10549-017-4597-6","article-title":"PRMT5 determines the sensitivity to chemotherapeutics by governing stemness in breast cancer","volume":"168","author":"Wang","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2025.189356_bb0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114842","article-title":"Medicinal chemistry strategies targeting PRMT5 for cancer therapy","volume":"244","author":"Fu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbcan.2025.189356_bb0935","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1111\/j.1349-7006.2012.02367.x","article-title":"Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G 1 cyclins\/cyclin-dependent kinases and the phosphoinositide 3-kinase\/ AKT signaling cascade","volume":"103","author":"Wei","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb0940","doi-asserted-by":"crossref","first-page":"791","DOI":"10.4161\/auto.23785","article-title":"CFLAR\/c-FLIP L: a star in the autophagy, apoptosis and necroptosis alliance","volume":"9","author":"He","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.bbcan.2025.189356_bb0945","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3390\/life11090951","article-title":"Structure, activity and function of the protein arginine methyltransferase 6","volume":"11","author":"Gupta","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.bbcan.2025.189356_bb0950","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1158\/1541-7786.MCR-19-0204","article-title":"PRMT6 promotes lung tumor progression via the alternate activation of tumor-associated macrophages","volume":"18","author":"Avasarala","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189356_bb0955","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/ijc.25366","article-title":"Dysregulation of PRMT1 and PRMT6, type I arginine methyltransferases, is involved in various types of human cancers","volume":"128","author":"Yoshimatsu","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb0960","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/ijc.33375","article-title":"Histone lysine demethylases and their functions in cancer","volume":"148","author":"Sterling","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb0965","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1878-0261.13124","article-title":"Intrinsic and acquired drug resistance to LSD1 inhibitors in small cell lung cancer occurs through a TEAD4-driven transcriptional state","volume":"16","author":"Yan","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbcan.2025.189356_bb0970","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1541-7786.MCR-20-0404","article-title":"Crucial functions of the JMJD1\/KDM3 epigenetic regulators in cancer","volume":"19","author":"Sui","year":"2021","journal-title":"Mol. Cancer Res. MCR"},{"key":"10.1016\/j.bbcan.2025.189356_bb0975","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1038\/ncomms3035","article-title":"A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth","volume":"4","author":"Wang","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2025.189356_bb0980","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ijc.31881","article-title":"KDM5 demethylases and their role in cancer cell chemoresistance","volume":"144","author":"Plch","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb0985","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108647","article-title":"Dynamic EMT: a multi-tool for tumor progression","volume":"40","author":"Brabletz","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2025.189356_bb0990","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1158\/0008-5472.CAN-12-3165","article-title":"Histone demethylase RBP2 promotes lung tumorigenesis and cancer metastasis","volume":"73","author":"Teng","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189356_bb0995","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00341-20","article-title":"Lysine demethylase KDM6A in differentiation, development, and cancer","volume":"40","author":"Tran","year":"2020","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2025.189356_bb1000","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1038\/s41388-020-01449-y","article-title":"Histone 3 lysine-27 demethylase KDM6A coordinates with KMT2B to play an oncogenic role in NSCLC by regulating H3K4me3","volume":"39","author":"Leng","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2025.189356_bb1005","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/gb-2011-12-4-220","article-title":"The cullin protein family","volume":"12","author":"Sarikas","year":"2011","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbcan.2025.189356_bb1010","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12943-020-01262-x","article-title":"The role of ubiquitination and deubiquitination in cancer metabolism","volume":"19","author":"Sun","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb1015","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.tig.2020.12.005","article-title":"Histone ubiquitination: An integrative signaling platform in genome stability","volume":"37","author":"Mattiroli","year":"2021","journal-title":"Trends Genet."},{"key":"10.1016\/j.bbcan.2025.189356_bb1020","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1073\/pnas.1322545111","article-title":"TRIM65 regulates microRNA activity by ubiquitination of TNRC6","volume":"111","author":"Li","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb1025","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41419-019-1660-8","article-title":"Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549\/DDP cells by regulating miR-138-5p\/ATG7","volume":"10","author":"Pan","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189356_bb1030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1126\/science.1065203","article-title":"Phosphorylation-dependent ubiquitination of cyclin E by the SCF Fbw7 ubiquitin ligase","volume":"294","author":"Koepp","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2025.189356_bb1035","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12935-020-01284-x","article-title":"MiR-223 regulates autophagy associated with cisplatin resistance by targeting FBXW7 in human non-small cell lung cancer","volume":"20","author":"Wang","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2025.189356_bb1040","doi-asserted-by":"crossref","first-page":"16281","DOI":"10.1073\/pnas.0905653106","article-title":"Highly tumorigenic lung cancer CD133 + cells display stem-like features and are spared by cisplatin treatment","volume":"106","author":"Bertolini","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb1045","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41392-022-00975-3","article-title":"Targeting non-coding RNAs to overcome cancer therapy resistance","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2025.189356_bb1050","doi-asserted-by":"crossref","first-page":"1105484","DOI":"10.3389\/fphar.2023.1105484","article-title":"Emerging role of non-coding RNAs in resistance to platinum-based anti-cancer agents in lung cancer","volume":"14","author":"Mondal","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189356_bb1055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105309","article-title":"Circular RNAs in lung cancer: implications for preventing therapeutic resistance","volume":"107","author":"Liu","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbcan.2025.189356_bb1060","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.949566","article-title":"miRNAs in anti-cancer drug resistance of non-small cell lung cancer: recent advances and future potential","volume":"13","author":"Yan","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189356_bb1065","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41417-020-00214-3","article-title":"Mechanisms of drug resistance mediated by long non-coding RNAs in non-small-cell lung cancer","volume":"28","author":"La Montagna","year":"2021","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bbcan.2025.189356_bb1070","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1186\/s12967-024-05877-2","article-title":"A review of the complex interplay between chemoresistance and lncRNAs in lung cancer","volume":"22","author":"Alnefaie","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2025.189356_bb1075","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.989","article-title":"Cancer-associated fibroblast-derived exosomal microRNA-20a suppresses the PTEN\/PI3K-AKT pathway to promote the progression and chemoresistance of non-small cell lung cancer","volume":"12","author":"Shi","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbcan.2025.189356_bb1080","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004832","article-title":"Snail-regulated exosomal microRNA-21 suppresses NLRP3 inflammasome activity to enhance cisplatin resistance","volume":"10","author":"Cheng","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb1085","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117238","article-title":"MiR-27b suppresses epithelial\u2013mesenchymal transition and chemoresistance in lung cancer by targeting Snail1","volume":"254","author":"Zhang","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb1090","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.14","article-title":"Therapeutic delivery of MicroRNA-29b by cationic lipoplexes for lung cancer","volume":"2","author":"Wu","year":"2013","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"10.1016\/j.bbcan.2025.189356_bb1095","doi-asserted-by":"crossref","first-page":"8007","DOI":"10.1038\/s41598-018-26381-w","article-title":"MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K\/Akt pathway","volume":"8","author":"Sun","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2025.189356_bb1100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10495-021-01665-1","article-title":"miR-30b-5p inhibits cancer progression and enhances cisplatin sensitivity in lung cancer through targeting LRP8","volume":"26","author":"Qiu","year":"2021","journal-title":"Apoptosis Int. J. Program. Cell Death"},{"key":"10.1016\/j.bbcan.2025.189356_bb1105","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s40364-023-00544-y","article-title":"Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancer","volume":"11","author":"de Miguel-Perez","year":"2023","journal-title":"Biomark. Res."},{"key":"10.1016\/j.bbcan.2025.189356_bb1110","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1080\/15384101.2016.1224043","article-title":"DNA damage responsive miR-33b-3p promoted lung cancer cells survival and cisplatin resistance by targeting p21WAF1\/CIP1","volume":"15","author":"Xu","year":"2016","journal-title":"Cell Cycle Georget. Tex."},{"key":"10.1016\/j.bbcan.2025.189356_bb1115","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41419-023-06125-z","article-title":"miR-92a-3p regulates cisplatin-induced cancer cell death","volume":"14","author":"Larrue","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189356_bb1120","doi-asserted-by":"crossref","first-page":"14456","DOI":"10.18632\/aging.103556","article-title":"Cancer-associated fibroblasts secreted miR-103a-3p suppresses apoptosis and promotes cisplatin resistance in non-small cell lung cancer","volume":"13","author":"Wang","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.bbcan.2025.189356_bb1125","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s12033-023-00662-w","article-title":"CYTOR promotes proliferation of lung cancer cell by targeting miR-103a-3p to upregulate HMGB1","volume":"65","author":"Xu","year":"2023","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.bbcan.2025.189356_bb1130","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41419-020-02962-4","article-title":"Bone marrow mesenchymal stem cells-derived exosomal microRNA-193a reduces cisplatin resistance of non-small cell lung cancer cells via targeting LRRC1","volume":"11","author":"Wu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189356_bb1135","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/bjc.2014.157","article-title":"MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G1\/S transition and apoptosis by targeting p21WAF1\/CIP1","volume":"111","author":"Wang","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb1140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41392-022-01228-z","article-title":"Role of the miR-301a\/Fra-2\/GLIPR1 axis in lung cancer cisplatin resistance","volume":"8","author":"Rampioni Vinciguerra","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2025.189356_bb1145","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3892\/ijo.2021.5267","article-title":"miR-383 increases the cisplatin sensitivity of lung adenocarcinoma cells through inhibition of the RBM24-mediated NF-\u03baB signaling pathway","volume":"59","author":"He","year":"2021","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2025.189356_bb1150","doi-asserted-by":"crossref","first-page":"8121","DOI":"10.2147\/IJN.S221383","article-title":"Exosomal transfer of cisplatin-induced miR-425-3p confers cisplatin resistance in NSCLC through activating autophagy","volume":"14","author":"Ma","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bbcan.2025.189356_bb1155","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119399","article-title":"Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis","volume":"276","author":"Song","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb1160","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.omtn.2022.03.020","article-title":"miR-6077 promotes cisplatin\/pemetrexed resistance in lung adenocarcinoma via CDKN1A\/cell cycle arrest and KEAP1\/ferroptosis pathways","volume":"28","author":"Bi","year":"2022","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"10.1016\/j.bbcan.2025.189356_bb1165","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1002\/cncr.26560","article-title":"MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3","volume":"118","author":"Feng","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb1170","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/s41419-019-2031-1","article-title":"MicroRNA-421 confers paclitaxel resistance by binding to the KEAP1 3\u2032UTR and predicts poor survival in non-small cell lung cancer","volume":"10","author":"Duan","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189356_bb1175","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12957-021-02278-3","article-title":"MiR-194-5p enhances the sensitivity of nonsmall-cell lung cancer to doxorubicin through targeted inhibition of hypoxia-inducible factor-1","volume":"19","author":"Xia","year":"2021","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.bbcan.2025.189356_bb1180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173105","article-title":"miR-199a-5p is involved in doxorubicin resistance of non-small cell lung cancer (NSCLC) cells","volume":"878","author":"Jin","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189356_bb1185","article-title":"MiR-451a attenuates doxorubicin resistance in lung cancer via suppressing epithelialmesenchymal transition (EMT) through targeting c-Myc","volume":"125","author":"Tao","year":"2020","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"10.1016\/j.bbcan.2025.189356_bb1190","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2018.4614","article-title":"LncRNA BLACAT1 is involved in chemoresistance of non-small cell lung cancer cells by regulating autophagy","author":"Huang","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2025.189356_bb1195","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.biopha.2018.02.130","article-title":"LncRNA-MALAT1 contributes to the cisplatin-resistance of lung cancer by upregulating MRP1 and MDR1 via STAT3 activation","volume":"101","author":"Fang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbcan.2025.189356_bb1200","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00280-019-03808-3","article-title":"The PVT1\/miR-216b\/Beclin-1 regulates cisplatin sensitivity of NSCLC cells via modulating autophagy and apoptosis","volume":"83","author":"Chen","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189356_bb1205","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1080\/15384101.2017.1361071","article-title":"LncRNA XIST promotes human lung adenocarcinoma cells to cisplatin resistance via let-7i\/BAG-1 axis","volume":"16","author":"Sun","year":"2017","journal-title":"Cell Cycle Georget. Tex."},{"key":"10.1016\/j.bbcan.2025.189356_bb1210","first-page":"12","article-title":"Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275\/PROCA1\/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma","volume":"42","author":"Tao","year":"2023","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.bbcan.2025.189356_bb1215","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.omtn.2019.01.005","article-title":"TFAP2C-activated MALAT1 modulates the chemoresistance of docetaxel-resistant lung adenocarcinoma cells","volume":"14","author":"Chen","year":"2019","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"10.1016\/j.bbcan.2025.189356_bb1220","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.canlet.2021.10.029","article-title":"Exosome-mediated transfer of SNHG7 enhances docetaxel resistance in lung adenocarcinoma","volume":"526","author":"Zhang","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2025.189356_bb1225","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100915","article-title":"Exosomal LOC85009 inhibits docetaxel resistance in lung adenocarcinoma through regulating ATG5-induced autophagy","volume":"67","author":"Yu","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bbcan.2025.189356_bb1230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2022.110294","article-title":"Circ_0004015 silencing represses cisplatin chemoresistance and tumor progression by reducing KLF8 in a miR-198-dependent manner in non-small cell lung cancer","volume":"114","author":"Li","year":"2022","journal-title":"Genomics"},{"key":"10.1016\/j.bbcan.2025.189356_bb1235","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1186\/s12935-020-01642-9","article-title":"Exosome-transferred hsa_circ_0014235 promotes DDP chemoresistance and deteriorates the development of non-small cell lung cancer by mediating the miR-520a-5p\/CDK4 pathway","volume":"20","author":"Xu","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2025.189356_bb1240","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116984","article-title":"Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296\u20135p","volume":"239","author":"Dong","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb1245","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13046-020-01648-1","article-title":"Circular RNA circ-CPA4\/ let-7 miRNA\/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC)","volume":"39","author":"Hong","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189356_bb1250","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12931-021-01840-7","article-title":"Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p\/ROCK1 axis","volume":"22","author":"Feng","year":"2021","journal-title":"Respir. Res."},{"key":"10.1016\/j.bbcan.2025.189356_bb1255","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.7150\/ijbs.84577","article-title":"Androgen receptor suppresses lung cancer invasion and increases cisplatin response via decreasing TPD52 expression","volume":"19","author":"Liu","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb1260","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/10717544.2022.2057617","article-title":"Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3\/SOX2 axis","volume":"29","author":"Xie","year":"2025","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bbcan.2025.189356_bb1265","doi-asserted-by":"crossref","first-page":"9070","DOI":"10.1080\/21655979.2022.2053803","article-title":"Circular RNA circ_0002360 regulates the Taxol resistance and malignant behaviors of Taxol-resistant non-small cell lung cancer cells by microRNA-585-3p-dependent modulation of G protein regulated inducer of neurite outgrowth 1","volume":"13","author":"Cui","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.bbcan.2025.189356_bb1270","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/s41419-019-2180-2","article-title":"Hsa_circ_0002483 inhibited the progression and enhanced the Taxol sensitivity of non-small cell lung cancer by targeting miR-182-5p","volume":"10","author":"Li","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189356_bb1275","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/1878-0261.12852","article-title":"A novel circular RNA, hsa_circ_0030998 suppresses lung cancer tumorigenesis and Taxol resistance by sponging miR-558","volume":"15","author":"Li","year":"2021","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbcan.2025.189356_bb1280","doi-asserted-by":"crossref","first-page":"15352","DOI":"10.3390\/ijms232315352","article-title":"miR-145-5p targets Sp1 in non-small cell lung cancer cells and links to BMI1 induced pemetrexed resistance and epithelial-mesenchymal transition","volume":"23","author":"Chang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb1285","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.7150\/ijbs.47203","article-title":"miRNA-based biomarkers, therapies, and resistance in cancer","volume":"16","author":"He","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb1290","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ejcb.2017.09.002","article-title":"BH3-only protein BIM: An emerging target in chemotherapy","volume":"96","author":"Shukla","year":"2017","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.bbcan.2025.189356_bb1295","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12943-024-01934-y","article-title":"Selective autophagy in cancer: mechanisms, therapeutic implications, and future perspectives","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb1300","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc3262","article-title":"Deconvoluting the context-dependent role for autophagy in cancer","volume":"12","author":"White","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb1305","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.taap.2016.09.009","article-title":"Inhibition of autophagy by andrographolide resensitizes cisplatin-resistant non-small cell lung carcinoma cells via activation of the Akt\/mTOR pathway","volume":"310","author":"Mi","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189356_bb1310","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11010-013-1795-3","article-title":"MiR-199a suppresses the hypoxia-induced proliferation of non-small cell lung cancer cells through targeting HIF1\u03b1","volume":"384","author":"Ding","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbcan.2025.189356_bb1315","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","article-title":"Long non-coding RNAs: definitions, functions, challenges and recommendations","volume":"24","author":"Mattick","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2025.189356_bb1320","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.molcel.2022.05.027","article-title":"Integrated lncRNA function upon genomic and epigenomic regulation","volume":"82","author":"Herman","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2025.189356_bb1325","article-title":"Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer","volume":"1875","author":"Goyal","year":"2021","journal-title":"Biochim. Biophys. Acta BBA - Rev. Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb1330","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110326","article-title":"MALAT1 enhances gemcitabine resistance in non-small cell lung cancer cells by directly affecting miR-27a-5p\/PBOV1 axis","volume":"94","author":"Chen","year":"2022","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbcan.2025.189356_bb1335","article-title":"The long noncoding RNA MEG3 contributes to cisplatin resistance of human lung adenocarcinoma","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2025.189356_bb1340","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1074\/jbc.M116.750950","article-title":"MEG3 long noncoding RNA contributes to the epigenetic regulation of epithelial-mesenchymal transition in lung cancer cell lines","volume":"292","author":"Terashima","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2025.189356_bb1345","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12943-020-1138-4","article-title":"Autophagy and autophagy-related proteins in cancer","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb1350","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41420-022-00886-w","article-title":"Hypoxia-induced PVT1 promotes lung cancer chemoresistance to cisplatin by autophagy via PVT1\/miR-140-3p\/ATG5 axis","volume":"8","author":"Wang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189356_bb1355","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.18632\/aging.102673","article-title":"Silencing of lncRNA XIST inhibits non-small cell lung cancer growth and promotes chemosensitivity to cisplatin","volume":"12","author":"Xu","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.bbcan.2025.189356_bb1360","doi-asserted-by":"crossref","first-page":"8095","DOI":"10.12659\/MSM.916075","article-title":"Upregulation of long noncoding RNA (lncRNA) X-inactive specific transcript (XIST) is associated with cisplatin resistance in non-small cell lung cancer (NSCLC) by downregulating MicroRNA-144-3p","volume":"25","author":"Tian","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.bbcan.2025.189356_bb1365","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12943-020-01240-3","article-title":"CircRNAs in anticancer drug resistance: recent advances and future potential","volume":"19","author":"Xu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb1370","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/med.21558","article-title":"A magic drug target: Androgen receptor","volume":"39","author":"Li","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbcan.2025.189356_bb1375","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ebiom.2019.08.057","article-title":"Loss of scribble confers cisplatin resistance during NSCLC chemotherapy via Nox2\/ROS and Nrf2\/PD-L1 signaling","volume":"47","author":"Wang","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbcan.2025.189356_bb1380","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41419-021-04033-8","article-title":"miR-526b-3p inhibits lung cancer cisplatin-resistance and metastasis by inhibiting STAT3-promoted PD-L1","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189356_bb1385","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1124\/pharmrev.121.000349","article-title":"Matrix metalloproteinases: from molecular mechanisms to physiology, pathophysiology, and pharmacology","volume":"74","author":"De Almeida","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbcan.2025.189356_bb1390","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109828","article-title":"CircPVT1 contributes to chemotherapy resistance of lung adenocarcinoma through miR-145-5p\/ABCC1 axis","volume":"124","author":"Zheng","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbcan.2025.189356_bb1395","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00204-022-03404-0","article-title":"CRISPR-based DNA methylation editing of NNT rescues the cisplatin resistance of lung cancer cells by reducing autophagy","volume":"97","author":"Xu","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bbcan.2025.189356_bb1400","article-title":"Decitabine sensitizes the radioresistant lung adenocarcinoma to pemetrexed through upregulation of folate receptor alpha","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2025.189356_bb1405","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1002\/cncr.31779","article-title":"ABOUND.2L+: a randomized phase 2 study of nanoparticle albumin-bound paclitaxel with or without CC-486 as second-line treatment for advanced nonsquamous non-small cell lung cancer (NSCLC)","volume":"124","author":"Morgensztern","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb1410","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.3390\/cancers13184614","article-title":"CBP\/p300 bromodomain inhibitor\u2013I\u2013CBP112 declines transcription of the key ABC transporters and sensitizes cancer cells to chemotherapy drugs","volume":"13","author":"Strachowska","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189356_bb1415","article-title":"I-CBP112 declines overexpression of ATP-binding cassette transporters and sensitized drug-resistant MDA-MB-231 and A549 cell lines to chemotherapy drugs","volume":"168","author":"Strachowska","year":"2023","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"10.1016\/j.bbcan.2025.189356_bb1420","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ijc.24759","article-title":"Vorinostat increases carboplatin and paclitaxel activity in non-small cell lung cancer cells","volume":"126","author":"Owonikoko","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb1425","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1200\/JCO.2009.24.9094","article-title":"Carboplatin and paclitaxel in combination with either vorinostat or placebo for first-line therapy of advanced non\u2013small-cell lung cancer","volume":"28","author":"Ramalingam","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2025.189356_bb1430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029085","article-title":"Synergistic antitumor effects of novel HDAC inhibitors and paclitaxel in vitro and in vivo","volume":"6","author":"Zuco","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2025.189356_bb1435","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41419-019-1597-y","article-title":"Targeting HDAC\/OAZ1 axis with a novel inhibitor effectively reverses cisplatin resistance in non-small cell lung cancer","volume":"10","author":"Sun","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189356_bb1440","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1186\/s12885-015-1967-5","article-title":"The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFR-mutated and -wildtype non-small cell lung cancer cells","volume":"15","author":"Greve","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb1445","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-4598-14-4","article-title":"Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1\u03b1 destabilization","volume":"14","author":"Fischer","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb1450","first-page":"4475","article-title":"Phase I trial of carboplatin and etoposide in combination with panobinostat in patients with lung cancer","volume":"33","author":"Tarhini","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbcan.2025.189356_bb1455","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e42733","article-title":"The role of miR-16 and miR-34a family in the regulation of cancers: a review","volume":"11","author":"Sadeghi","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.bbcan.2025.189356_bb1460","doi-asserted-by":"crossref","first-page":"13357","DOI":"10.3390\/ijms222413357","article-title":"MicroRNA-16 restores sensitivity to tyrosine kinase inhibitors and outperforms MEK inhibitors in KRAS-mutated non-small cell lung cancer","volume":"22","author":"Fanini","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189356_bb1465","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S1470-2045(17)30621-6","article-title":"Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study","volume":"18","author":"van Zandwijk","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2025.189356_bb1470","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189356_bb1475","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/COC.0000000000001106","article-title":"The microRNA-34 family and its functional role in lung cancer","volume":"47","author":"Zhang","year":"2024","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2025.189356_bb1480","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41598-017-00913-2","article-title":"LF-MF inhibits iron metabolism and suppresses lung cancer through activation of P53-miR-34a-E2F1\/E2F3 pathway","volume":"7","author":"Ren","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2025.189356_bb1485","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.582370","article-title":"Histone deacetylase inhibition in non-small cell lung cancer: hype or hope?","volume":"8","author":"Mamdani","year":"2020","journal-title":"Front. Cell Dev. Biol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25000988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25000988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:01:56Z","timestamp":1777554116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X25000988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":297,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0304419X25000988"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189356","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic mechanisms in non-small cell lung cancer therapy and chemoresistance","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189356"}}